Syngenis joins WA research heavyweights in RNA medicine push
Perth biotech Syngenis Labs has teamed up with two of WA’s research giants, Perron and Murdoch Uni, to develop rare-disease RNA medicines, opening a new commercial frontier ahead of its planned ASX listing.